Literature DB >> 17493145

Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours.

D Middleton1, J R Vilchez, T Cabrera, A Meenagh, F Williams, I Halfpenny, I Maleno, F Ruiz-Cabello, M A Lopez-Nevot, F Garrido.   

Abstract

Three cohorts of patients with laryngeal, bladder or colorectal tumours were investigated for frequency of killer immunoglobulin-like receptor (KIR) genes compared with a normal control population. The frequency of KIR3DL1 and KIR2DS4 was significantly increased (but not after correction for number of comparisons made) in patients with bladder tumour compared with controls. No other significant differences were found in gene frequencies or in the frequencies of those KIR genes with and without their human leucocyte antigen (HLA) ligands. Furthermore, no significant differences were found in KIR gene frequencies, taking into consideration the type of loss of HLA expression in the individual tumours. Finally, in the group of colorectal carcinomas, there was an overall significant difference in the frequencies of C group heterozygosity and homozygosity with HLA alterations on the tumour.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493145     DOI: 10.1111/j.1399-0039.2006.00792.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  12 in total

1.  Diversity of the KIR gene cluster in an urban Brazilian population.

Authors:  D G Augusto; L Zehnder-Alves; M R Pincerati; M P Martin; M Carrington; Maria Luiza Petzl-Erler
Journal:  Immunogenetics       Date:  2011-08-18       Impact factor: 2.846

2.  KIRs gene content diversity in Iranians with urothelial bladder cancer.

Authors:  Elham Jamali; Shaghik Barani; Fahimeh Yousefinejad; Ali Ariafar; Ghoalm Reza Talei; Abbas Ghaderi
Journal:  Mol Biol Rep       Date:  2018-07-02       Impact factor: 2.316

3.  Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.

Authors:  Kemal Beksac; Meral Beksac; Klara Dalva; Ergun Karaagaoglu; M Bulent Tirnaksiz
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

4.  Colorectal cancer and the KIR genes in the human genome: A meta-analysis.

Authors:  Koroush Ghanadi; Bahareh Shayanrad; Seyyed Amir Yasin Ahmadi; Farhad Shahsavar; Hossein Eliasy
Journal:  Genom Data       Date:  2016-11-01

5.  Strong evidence for LncRNA ZNRD1-AS1, and its functional Cis- eQTL locus contributing more to the susceptibility of lung cancer.

Authors:  Dan Li; Lei Song; Zhongmei Wen; Xiaoping Li; Jing Jie; Yan Wang; Liping Peng
Journal:  Oncotarget       Date:  2016-06-14

6.  The association of HLA/KIR genes with non-small cell lung cancer (adenocarcinoma) in a Han Chinese population.

Authors:  Yingfu Li; Shuyuan Liu; Chao Hong; Qianli Ma; Fang Tan; Chengxiu Liu; Piotr Kuśnierczyk; Chuanyin Li; Li Shi; Yufeng Yao
Journal:  J Cancer       Date:  2019-08-20       Impact factor: 4.207

7.  Expression of NK Cell Receptor Ligands on Leukemic Cells Is Associated with the Outcome of Childhood Acute Leukemia.

Authors:  María Victoria Martínez-Sánchez; José Luis Fuster; José Antonio Campillo; Ana María Galera; Mar Bermúdez-Cortés; María Esther Llinares; Eduardo Ramos-Elbal; Juan Francisco Pascual-Gázquez; Ana María Fita; Helios Martínez-Banaclocha; José Antonio Galián; Lourdes Gimeno; Manuel Muro; Alfredo Minguela
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

8.  Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.

Authors:  Valli De Re; Laura Caggiari; Mariangela De Zorzi; Renato Talamini; Vito Racanelli; Mario D' Andrea; Angela Buonadonna; Vittorina Zagonel; Erika Cecchin; Federico Innocenti; Giuseppe Toffoli
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.

Authors:  Angelica Canossi; Anna Aureli; Tiziana Del Beato; Piero Rossi; Luana Franceschilli; Flavio De Sanctis; Pierpaolo Sileri; Nicola di Lorenzo; Oreste Buonomo; Davide Lauro; Adriano Venditti; Giuseppe Sconocchia
Journal:  J Transl Med       Date:  2016-08-12       Impact factor: 5.531

Review 10.  The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?

Authors:  Danillo G Augusto
Journal:  Front Genet       Date:  2016-06-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.